Articles

Showing 3 articles

• Original Research

  Published 28 September 2026

  A prospective study evaluating clopidogrel resistance among patients with ischemic cerebrovascular events across different ethnic groups in Israel

  Fadi Shbat · Karine Beiruti Wiegler · Najib Dally · Elias Saad · Saher Srour · Elizabeth Eshel · Adi Sharabi Nov · Radi Shahien · Ronen Leker · Naaem Simaan

  Frontiers in Stroke

  doi 10.3389/fstro.2026.1908099

• Perspective

  Published 25 August 2026

  Cardiometabolic drugs after stroke: time to embrace SGLT2 inhibitors and incretin-based therapies?

  Håkon Ihle-Hansen · Hege Ihle-Hansen · Rolf A. Blauenfeldt · Jesse Dawson · Søren Z. Diederichsen · Guri Hagberg

  Frontiers in Stroke

  doi 10.3389/fstro.2026.1918465

• Clinical Trial

  Published 13 April 2026

  Comparison of primary and secondary stroke outcomes between government and private healthcare institutions: insights from the SPRINT India trial

  Shweta Jain Verma · Bhavya Nanda · Paramdeep Kaur · Arya Devi K. S. · Deepti Arora · Aneesh Dhasan · P. N. Sylaja · Dheeraj Khurana · Vijaya Pamidimukkala · Biman Kanti Ray · Vivek Nambiar · Sanjith Aaron · Gaurav Mittal · Aparna R. Pai · Sankar Prasad Gorthi · Somasundaram Kumaravelu · Yerasu Muralidhar Reddy · Sunil Narayan · Nomal Chandra Borah · Rupjyoti Das · Girish Baburao Kulkarni · Vikram Huded · Thomas Mathew · Rohit Bhatia · Pawan Kumar Ojha · Jayanta Roy · Anand Girish Vaishnav · Arvind Sharma · Abhishek Pathak · Sanjeev Kumar Bhoi · Sudhir Sharma · Sulena Sulena · Aralikatte Onkarappa Saroja · Neetu Ramrakhiani · Madhusudhan Byadarahalli Kempegowda · Mahesh Kate · Tina George · Ivy Sebastian · Meenakshi Sharma · Rupinder Dhaliwal · Jeyaraj D. Pandian

  Frontiers in Stroke

  doi 10.3389/fstro.2026.1805422